4/2
08:30 am
drts
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
Medium
Report
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
3/17
11:20 am
drts
Alpha Tau Medical Ltd. (NASDAQ: DRTS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
Alpha Tau Medical Ltd. (NASDAQ: DRTS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
3/15
05:28 pm
drts
Deadly cancer type linked to obesity and high stress levels [FOX News]
Low
Report
Deadly cancer type linked to obesity and high stress levels [FOX News]
3/12
04:02 pm
drts
Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
Low
Report
Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
2/27
09:07 am
drts
Alpha Tau to Participate in March Investor Conferences [Yahoo! Finance]
Medium
Report
Alpha Tau to Participate in March Investor Conferences [Yahoo! Finance]
2/27
09:00 am
drts
Alpha Tau to Participate in March Investor Conferences
Medium
Report
Alpha Tau to Participate in March Investor Conferences
2/24
08:41 am
drts
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification [Yahoo! Finance]
Medium
Report
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification [Yahoo! Finance]
2/24
08:30 am
drts
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
Medium
Report
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
2/3
09:25 am
drts
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease [Yahoo! Finance]
Low
Report
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease [Yahoo! Finance]
2/3
08:30 am
drts
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
Medium
Report
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
1/27
09:00 am
drts
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
Medium
Report
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day